D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes

Biological Psychiatry

Volumn 40, Issue 9, 1996, Pages 881-885

  Vile, John M ^a   Strange, Philip G ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

D2 like dopamine receptors; Lymphocytes; Messenger RNA; Neuroleptics; Schizophrenia; Stereoselectivity

Indexed keywords

BUTACLAMOL; DOPAMINE 2 RECEPTOR; EMONAPRIDE; HALOPERIDOL; SULPIRIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030298493     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00498-X     Document Type: Article

References (27)

1. Amenta F, Ferrante F, Rossodivita A, Ricci A (1992): Pharmacological characterisation and autoradiographic localisation of dopamine receptors in human epicardial arteries. J Pharmacol Exp Ther 263:1447-1453.
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington DC: American Psychiatric Association.
3. Bondy B, Ackenheil M, Birzle W, Elbers R, Frohler M (1984): Catecholamines and their receptors in blood: Evidence for alterations in schizophrenia. Biol Psychiatry 19:1377-1393.
4. 3H]-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J Psychiatr Res 21:521-530.
5. 3H-spiperone binding to lymphocytes. J Psychiatr Res 24:83-92.
6. Bondy B, Ackenheil M, Ruppert T (1992): Spiperone binding in lymphocytes: part of a dopamine uptake system? Ann NY Acad Sci 650:221-225.
7. Castro SW, Strange PG (1993): Coupling of D2 and D3 dopamine receptors to G-proteins. FEBS Lett 315:223-226.
8. Chomczynski P, Sacchi N (1987): Single step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Tol HMM (1991): Molecular biology of the dopamine receptors. Eur J Pharmacol 207:277-286.
10. 3H-Spiperone labels sigma receptors, not dopamine D2 receptors in rat and human lymphocytes. Immunopharmacology 22:93-106.
11. Grandy DK, Marchionni MA, Haripriya M, Bunzow JR, Server AC, Civelli O (1989): Cloning of the cDNA and gene for a human D2 receptor. Proc Natl Acad Sci 86:9762-9766.
12. 3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients. Biol Psychiatry 27:1327-1330.
13. Kebabian JW, Calne DB (1979): Multiple receptors for dopamine. Nature 277:93-96.
14. LeFur G, Phan T, Uzan A (1980): Identification of stereospecific 3H-spiroperidol binding sites in mammalian lymphocytes. Life Sci 26:1139-1148.
15. 3H] hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci 89:8155-8159.
16. Livnat S, Felten SY, Carlson SL, Bellinger DL, Felten DL (1985): Involvement of peripheral and central catecholamine systems in neural immune reactions. J Neuroimmunol 10:5-30.
17. Nagai Y, Ueno S, Saeki Y, Soga F, Yanagihara T (1993): Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem Biophys Res Commun 194:368-374.
18. Rao ML, Deister A, Roth A (1990): Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol. Pharmacopsychiatry 23:176-181.
19. 3H]7-OH-DPAT. J Neuroimmunol 58:139-144.
20. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular cloning: A laboratory manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
21. Santambrogio L, Lipartiti M, Bruni A, Dal Toso R (1993): Dopamine receptors on human T-and B-lymphocytes. J Neuroimmunol 45:113-120.
22. Sibley DR, Monsma FJ (1992): Molecular biology of dopamine receptors. Trends Pharm Sci 13:61-69.
23. Strange PG (1993): New insights into dopamine receptors in the central nervous system. Neurochem Int 22:223-236.
24. Takahashi N, Nagai Y, Ueno S, Saeki Y, Yanagihara T (1992): Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the 2 pseudogenes. FEBS Lett 314:23-25.
25. Tang L, Todd R, Heller A, O'Malley KL (1994): Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268:495-502.
26. Vile JM, Strange PG (1995): High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes and their relation to dopamine receptors. Biochem Pharm 49:747-753.
27. Zaleman SJ, Neckers LM, Kaayalp O, Wyatt RJ (1981): Muscarinic cholinergic binding sites on intact human lymphocytes. Life Sci 29:69-73.